Rydapt

Last Updated: 04/28/2026

Need to find the closest trial?
Sort By Distance
Save trials for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
1 clinical trial found

    Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML

    Phase II Study of Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With AML, HR MDS, or Myeloid Blast Phase of CML

    Who is this study for: Adult patients with Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, or Myelodysplastic Syndrome
    Enrollment Status: Recruiting
    Publish Date: November 06, 2025
    Intervention Type: Drug, Other
    Study Drugs: Cladribine, Cytarabine, Gliteritinib, Idarubicin, Midostaurin, Venetoclax
    Study Phase: Phase 2

    Summary: This phase II trial studies how well cladribine, idarubicin, cytarabine, and venetoclax work in patients with acute myeloid leukemia, high-risk myelodysplastic syndrome, or blastic phase chronic myeloid leukemia. Drugs used in chemotherapy, such as cladribine, idarubicin, cytarabine, and venetoclax, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping...

    Showing 1-1 of 1

    Last Updated: 04/28/2026